“Over the previous decade we have now remodeled the US enterprise from a largely retail particular person life and annuities enterprise to a high-performing market main advantages enterprise,” stated Dan Fishbein, president, Solar Life Monetary US. “The DentaQuest acquisition continues this evolution, altering the footprint of our enterprise within the US into a bigger, extra healthcare-focused group, now with greater than 70% of our advantages income coming from healthcare.
“These adjustments have transitioned Solar Life US from a capital-intensive to a capital-light enterprise with sturdy money move technology; from companies with long-term threat profiles to largely short-term threat and fee-based companies; from slow-growth markets to increased progress markets; and from return on fairness (ROE) within the single digits to a return on tangible fairness within the excessive teenagers.”
Learn subsequent: Solar Life experiences combined monetary ends in Q2
Headquartered in Boston and based in 2001, DentaQuest introduced greater than 33 million members in 36 states and greater than 2,400 workers throughout to Solar Life US. On the time of acquisition, it was the most important supplier of US Medicaid dental advantages, with rising Medicare Benefit, business, and US Reasonably priced Care Act (ACA) trade companies.
The management workforce for the mixed dental advantages enterprise underneath Solar Life US consists of a mix of DentaQuest and Solar Life leaders, all of whom are targeted on progress methods, income synergies, and optimizing efficiency, in line with Fishbein.
“We’re approaching integration with nice care and our objective is to appreciate the complete potential of the transaction for all our stakeholders, together with offering enhanced choices for purchasers, delivering our accretion and value financial savings targets for shareholders, creating new alternatives for our workers, and delivering a constructive integration expertise for all,” he defined.
“Now we have a robust observe file of efficiently integrating group advantages companies, whereas minimizing disruption for our purchasers. Most of the leaders who managed the Assurant integration are concerned within the DentaQuest integration. We’re targeted on integration actions that may assist our run price value financial savings goal of $60 million by 2024. We’re off to a robust begin with a completely built-in management workforce, engaged workers, and an in depth plan for the remaining steps.”
Solar Life US introduced its second quarter 2022 monetary outcomes on August 3, through which it reported insurance coverage gross sales of $213 million, up 12% year-over-year, pushed by increased dental and medical stop-loss gross sales. The enterprise reported web revenue of $213 million, up by 36%, or $56 million, from the prior yr interval, however partially offset by prices associated to the DentaQuest acquisition.
Learn extra: Met Life trumps analyst expectations on sturdy premiums and charges
When Solar Life first introduced the DentaQuest deal, it gave an accretion projection of a further 42 foundation factors to underlying ROE in 2022 on an annualized foundation. In 2024, upon realization of expense synergies, Solar Life expects the acquisition so as to add roughly 50 foundation factors to underlying ROE.
“The underlying earnings for DentaQuest within the one month [June 2022] was $10 million,” stated Fishbein. “We’re nonetheless assured within the accretion projections that we made once we introduced the transaction, and positively, the ends in June would assist that. We did see increased margins in June than maybe we anticipated, and a bit decrease revenues, however the increased margins greater than made up for the small variance in revenues. General […] this primary month provides us confidence in our prior projections.”
Fishbein stated he’s excited concerning the future at Solar Life US, including: “We now have 4 sturdy companies with market main positions in dental and stop-loss, and a prime 10 worker advantages enterprise. Though latest outcomes have been considerably masked by COVID impacts, as soon as this subsides, we stay assured in attaining our medium-term targets for the US, together with 10% or extra earnings progress for our advantages companies.”
